Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Hung

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|March 15, 1988
Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological propertiesN K Kalyan, S G Lee, J Wilhelm, et al.
Vaccine|January 1, 1992
Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSVM Connors, P L Collins, C Y Firestone, et al.
Vaccine|May 1, 1994
Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret modelK H Hsu, M D Lubeck, B M Bhat, et al.
Molecular Pharmacology|April 1, 1993
Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptorP K Chanda, M C Minchin, A R Davis, et al.
Archives of Virology|January 1, 1991
Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vectorW W Ye, B B Mason, M Chengalvala, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Biological properties of hybrid plasminogen activatorsP P Hung, J Wilhelm, N K Kalyan, et al.
Journal of Virology|November 1, 1992
Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutantS M Cheng, S G Lee, M Ronchetti-Blume, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccinesP P Hung, P K Chanda, R J Natuk, et al.
Vaccine|June 1, 1994
Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1N K Kalyan, S G Lee, J Wilhelm, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|March 15, 1988
Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological propertiesN K Kalyan, S G Lee, J Wilhelm, et al.
Vaccine|January 1, 1992
Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSVM Connors, P L Collins, C Y Firestone, et al.
Vaccine|May 1, 1994
Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret modelK H Hsu, M D Lubeck, B M Bhat, et al.
Molecular Pharmacology|April 1, 1993
Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptorP K Chanda, M C Minchin, A R Davis, et al.
Archives of Virology|January 1, 1991
Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vectorW W Ye, B B Mason, M Chengalvala, et al.
Advances in Experimental Medicine and Biology|January 1, 1990
Biological properties of hybrid plasminogen activatorsP P Hung, J Wilhelm, N K Kalyan, et al.
Journal of Virology|November 1, 1992
Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutantS M Cheng, S G Lee, M Ronchetti-Blume, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccinesP P Hung, P K Chanda, R J Natuk, et al.
Vaccine|June 1, 1994
Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1N K Kalyan, S G Lee, J Wilhelm, et al.
Pageof 7